Skip to main
SNYR

SNYR Stock Forecast & Price Target

SNYR Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Synergy CHC is poised for future growth with strong Q4 results, a focus on new products and international expansion, and an undervalued valuation. While facing competition and regulatory challenges, the company's FOCUSfactor brand has shown significant growth and its presence in the health and wellness market, along with its partnerships and distribution, bode well for potential high rewards. With a solid financial foundation and a promising market outlook, Synergy CHC is a promising opportunity for investors.

Bears say

Synergy CHC is facing some major challenges in its path to growth and profitability. These include the termination of its recent ME distribution deal, risks related to its balance sheet and liquidity, changes in demand for health and wellness products, increased competition, and potential changes in macroeconomic factors. Additionally, the company's stock has been weak and volatile over the past year, and its financial performance has been relatively flat. The company's recent growth has been driven by expanded distribution of its FOCUSfactor product line, but it faces risks in its expansion plans in international markets.

SNYR has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Synergy CHC Corp (SNYR) Forecast

Analysts have given SNYR a Strong Buy based on their latest research and market trends.

According to 2 analysts, SNYR has a Strong Buy consensus rating as of Jun 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Synergy CHC Corp (SNYR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.